Effects of the I(K.ATP) blockers glibenclamide and HMR1883 on cardiac electrophysiology during ischemia and reperfusion

European Journal of Pharmacology

Volumn 398, Issue 2, 2000, Pages 273-284

  Dhein, Stefan ^a   Pejman, Pantea ^b   Krüsemann, Kathi ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Arrhythmia; Cardiac ischemia; Dispersion; Glibenclamide; HMR1883; I(K.ATP); Sulfonylurea

Indexed keywords

1 [[5 [2 (5 CHLORO 2 ANISAMIDO)ETHYL] 2 METHOXYPHENYL]SULFONYL] 3 METHYLTHIOUREA; ADENOSINE TRIPHOSPHATE; CLAMIKALANT; GLIBENCLAMIDE; NEW DRUG; POTASSIUM CHANNEL BLOCKING AGENT; SULFATHIOUREA DERIVATIVE; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY LIGATION; ELECTROCARDIOGRAM; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART VENTRICLE FIBRILLATION; HYPEREMIA; ISOLATED HEART; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY;

ANIMALS; ARRHYTHMIA; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; GLYBURIDE; HEART; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RABBITS; SULFONAMIDES; THIOUREA; VENTRICULAR FIBRILLATION;

EID: 0034674502     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00322-8     Document Type: Article

References (41)

1. Arisi G., Macchi E., Baruffi S., Spaggiari S., Taccardi B. Potential field on the ventricular surface of the exposed dog heart during normal excitation. Circ. Res. 52:1983;706-715.
2. Ballagi-Pordany G., Koszeghy A., Koltai M.Z., Aranyi Z., Pogatsa G. Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds. Diabetes Res. Clin. Pract. 8:1990;109-114.
3. Barrett T.D., Walker M.J.A. Glibenclamide does not prevent action potential shortening induced by ischemia in anaesthetized rabbits but reduces ischemia-induced arrhythmias. J. Mol. Cell. Cardiol. 30:1998;999-1008.
4. Billman G.E., Avendano C.E., Halliwill J.R., Burroughs J.M. The effects of the ATP-dependent potassium channel antagonist, glyburide, on coronary blood flow and susceptibility to ventricular fibrillation in unanesthetized dogs. J. Cardiovasc. Pharmacol. 21:1993;197-204.
5. Billman G.E., Englert H.C., Schölkens B.A. HMR1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: Effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J. Pharmacol. Exp. Ther. 286:1998;1465-1473.
6. Brady P.A., Al-Sudawi J., Kopecky S.L., Terzic A. Sulfonylureas and mortality in diabetic patients after myocardial infarction. Circulation. 97:1998;709-710.
7. Cacciapuoti F., Spieza R., Bianchi U., Lama D., D'Avino M., Varricchio M. Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitus. Am. J. Cardiol. 67:1991;843-847.
8. Coronel R., Fiolet J.W.T., Wilms-Schopman F.J.G., Schaapherder A.F.M., Johnson T.A., Gettes L.S., Janse M.J. Distribution of extracellular potassium and its relation to electrophysiologic changes during acute myocardial ischemia in the isolated perfused porcine heart. Circulation. 77:1988;1125-1138.
9. D'Alonzo A.J., Sewter J.C., Darbenzio R.B., Hess T.A. Effects of cromakalim or glibenclamide on arrhythmias and dispersion of refractoriness in chronically infarcted anaesthetized dogs. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;222-228.
10. Davis T.M.E., Parsons R.W., Broadhurst R.J., Hobbs M.S.T., Jamrozik K. Arrhythmias and mortality after myocardial infarction in diabetic patients: relationship to diabetes treatment. Diabetologia. 39:1996;A51.
11. Davis T.M.E., Parsons R.W., Broadhurst R.J., Hobbs M.S.T., Jamrozik K. Arrhythmias and mortality after myocardial infarction in diabetic patients. Diabetes Care. 21:1998;637-640.
12. Dekker L.R.C., Fiolet J.W.T., Van Bavel E., Coronel R., Opthof T., Spaan J.A.E., Janse M.J. Intracellular Ca++, intercellular electrical coupling, and mechanical activity in ischemic rabbit papillary muscle. Effects of preconditioning and metabolic blockade. Circ. Res. 79:1996;237-246.
13. Dhein S., Rutten P., Klaus W. A new method for analysing the geometry and timecourse of epicardial potential spreading. Int. J. Biomed. Computing. 23:1988;201-207.
14. Dhein S., Müller A., Gerwin R., Klaus W. Comparative study on the proarrhythmic effects of some class I antiarrhythmic agents. Circulation. 87:1993;617-631.
15. DiDiego J.M., Antzelevitch C. Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissue: does activation of ATP-regulated potassium current promote phase 2 reentry? Circulation. 88:1993;1177-1189.
16. Durrer D., Van der Tweel L.H. Spread of activation in the left ventricular wall of the dog. Activation conditions at the epicardial surface. Am. Heart J. 47:1954;192-203.
17. Garrat K.N., Brady P.A., Hassinger N.L., Grill D.E., Terzic A., Holmes D.R. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J. Am. Coll. Cardiol. 33:1999;119-124.
18. ATP channels in guinea pig hearts and on rat pancreatic β-cells. Br. J. Pharmacol. 124:1998;23P. (Suppl.); (Abstract).
19. Gögelein H., Hartung J., Englert H.C., Schölkens B.A. HMR1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. I. Effects on cardiomyocytes, coronary flow and pancreatic β-cells. J. Pharmacol. Exp. Ther. 286:1998;1453-1464.
20. Gottwald E., Gottwald M., Dhein S. Enhanced dispersion of epicardial activation-recovery intervals at sites of histological inhomogeneity during regional ischaemia and reperfusion. Heart. 79:1998;474-480.
21. ATP channels. Diabetes. 47:1998;1412-1418.
22. Han J., Moe G.K. Nonuniform recovery of excitability in ventricular muscle. Circ. Res. 16:1964;46-60.
23. Janse M.J. Mapping in acutely ischemic myocardium. Shenasa M., Borggrefe M., Breithardt G. Cardiac Mapping. 1993;115-123 Futura Publishing, Mount Kisco, NY.
24. + channel in mammalian cardiac cells. Nature. 309:1984;354-356.
25. Kim D., Clampham D.E. Postassium channel in cardiac cells activated by arachidonic acid and phospholipids. Science. 244:1989;1174-1176.
26. Kléber A.G. Extracellular potassium accumulation in acute myocardial ischemia. J. Mol. Cell. Cardiol. 16:1984;389-394.
27. Kléber A.G., Janse M.J., van Capelle F.J.L., Durrer D. Mechanism and time course of ST and TQ segment changes during acute regional myocardial ischemia in the pig heart determined by extracellular and intracellular recordings. Circ. Res. 42:1978;603-613.
28. Kuo C.S., Munakata K., Reddy C.P., Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation. 67:1983;1356-1367.
29. Lomuscio A., Fiorentini C. Influence of oral antidiabetic treatment on electrocardiac alterations induced by myocardial infarction. Diabetes Res. Clin. Pract. 31:1996;S21-S26. (Suppl.).
30. Lomuscio A., Vergani D., Marano L., Castagnone M., Fiorentini C. Effects of glibenclamide on ventricular fibrillation in non-insulin-dependent diabetics with acute myocardial infarction. Cor. Art. Dis. 5:1994;767-771.
31. Millar C.K., Kralios F.A., Lux R.L. Correlation between refractory periods and activation recovery intervals from electrograms: effects of rate and adrenergic interventions. Circulation. 72:1985;1372-1379.
32. Morita Y., Murakami T., Iwase T., Naai K., Nawada R., Kouchi I., Akao M., Sasayama S. K(ATP) channels contribute to the cardioprotection of preconditioning independent of anaesthetics in rabbit hearts. J. Mol. Cell. Cardiol. 29:1997;1267-1276.
33. Munch-Ellingsen J., Bugge E., Ytrehus K. Blockade of the KATP-channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning. Basic Res. Cardiol. 91:1996;382-388.
34. +-channels in cardiac muscle. Nature. 305:1983;147-148.
35. Reensma P.L., Allessie M.A., Lammers W.J.E.P., Bonke F.I.M., Schalij M.J. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ. Res. 62:1988;395-410.
36. Schotborgh C.E., Wilde A.A.M. Sulfonylurea derivatives in cardiovascular research and in cardiovascular patients. Cardiovasc. Res. 34:1997;73-80.
37. Schultz J.E., Yao Z., Cavero I., Gross G.J. Glibenclamide-induced blockade of ischemic preconditioning is time-dependent in intact rat heart. Am. J. Physiol. 272:1997;H2607-H2615.
38. Smeets J.L.R.M., Allessie M.A., Lammers W.J.E.P., Bonke F.I.M., Hollen J. The wave length of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium. Circ. Res. 58:1986;96-108.
39. Thornton J.D., Thornton C.S., Sterling D.L., Downey J.M. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ. Res. 72:1993;44-49.
40. Wilde A.A.M. K+ATP-channel opening and arrhythmogenesis. J. Cardiovasc. Pharmacol. 24(Suppl. 4):1994;S35-S40.
41. Wilde A.A.M., Escande D., Schumacher C.A., Thuringer D., Mestre M., Fiolet J.W.T., Janse M.J. Potassium accumulation in the globally ischemic mammalian heart. A role for the ATP-sensitive potassium channel. Circ. Res. 67:1990;835-843.